Overview

This book analyzes all aspects of metronomic chemotherapy, a new approach involving low-dose, long-term, and frequently administered therapy that has preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are discussed. Clinical applications of metronomic chemotherapy in a wide variety of tumors are then addressed in detail, with description of the results of all published studies. The clinical pharmacology of metronomic chemotherapy is also considered in depth, encompassing pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions. The book closes by describing the role of this therapy in the veterinarian clinic.

Full Product Details

Author:   Guido Bocci ,  Giulio Francia
Publisher:   Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint:   Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition:   2014 ed.
Dimensions:   Width: 15.50cm , Height: 1.80cm , Length: 23.50cm
Weight:   0.646kg
ISBN:  

9783662436035

ISBN 10:   3662436035
Pages:   295
Publication Date:   26 September 2014
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Part I: Pharmacological bases of metronomic chemotherapy: The metronomic concept.- Antiangiogenic effects of metronomic chemotherapy.- Effects of metronomic chemotherapy on immunity.- Other proposed mechanism of action of metronomic chemotherapy. Part II: Preclinical studies of metronomic chemotherapy: Alkylating agents.- Camptothecins.- Fluoropyrimidines.- Taxanes.- Vinca alkaloids.- Anthracyclines.- Other drugs.- Part III. Drugs combined with metronomic chemotherapy in preclinical studies: Tyrosine kinase inhibitors.- Monoclonal antibodies.- Tumor vaccines.- Other drugs. Part IV. Clinical activity of metronomic chemotherapy: Breast cancers.- Prostate cancers.- Gastrointestinal cancers.- CNS cancers.- Pediatric malignancies.- Sarcomas.- Hematological cancers.- Liver cancers.- Gynecologic Cancers.- Lung cancers.- Other cancers. Part V: Clinical Pharmacology of metronomic chemotherapy: Pharmacokinetics of metronomic chemotherapy.- Pharmacodynamics of metronomic chemotherapy.- Pharmacogenetics of metronomic chemotherapy.- Pharmacoeconomics of metronomic chemotherapy and its social impact.- Adverse drug reactions of metronomic chemotherapy. Part VI:  Metronomic chemotherapy in veterinarian clinic: Clinical studies of metronomic chemotherapy alone.- Clinical studies of metronomic chemotherapy and other drugs.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions